Physician profile
Sarah D Corn
NPI 1003252461
$15,258.07
in general payments reported to CMS, 2019-2025
12 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.17 · 2021: $7,678 · 2022: $2,282 · 2023: $273 · 2024: $4,593 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,978 · Food and Beverage: $2,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,977.90 |
| Food and Beverage | $2,305.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,865.12 | 2021-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $533.92 | 2024-2025 | Spyglass Discover |
| Davol INC. | $289.55 | 2022-2024 | Arista Ah Flexitip |
| Conmed Corporation | $191.40 | 2022-2024 | Airseal |
| Myriad Genetic Laboratories, INC. | $171.85 | 2023-2024 | Myrisk |
| Vertex Pharmaceuticals Incorporated | $87.39 | 2025 | |
| Hologic Sales and Service, LLC | $38.15 | 2023 | Coolseal Generator |
| Polynovo North America LLC | $20.07 | 2023 | |
| Medtronic, INC. | $16.01 | 2025 | Signia |
| Springworks Therapeutics, INC. | $15.55 | 2025 | Gomekli |
| Abbvie INC. | $15.17 | 2019 | |
| Reprise Biomedical, INC. | $13.89 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Corn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.